Prosecution Insights
Last updated: April 19, 2026

Takeda Vaccines Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18030647 METHODS FOR DETERMINING COMPLEMENT-FIXING ANTIBODIES PENNINGTON, HALLIE NICOLE 1671 Non-Final OA Apr 06, 2023
18113193 COMPOSITIONS AND METHODS FOR STABILIZING FLAVIVIRUSES WITH IMPROVED FORMULATIONS CHESTNUT, BARRY A 1672 Non-Final OA Feb 23, 2023
18149742 DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF BLUMEL, BENJAMIN P 1671 Non-Final OA Jan 04, 2023
17999131 METHOD FOR DETERMINING THE POTENCY OF ANTIGENS BOESEN, AGNIESZKA 1672 Non-Final OA Nov 17, 2022
17416810 NOROVIRUS VACCINE FORMULATIONS AND METHODS SIFFORD, JEFFREY MARK 1671 Non-Final OA Jun 21, 2021
17274016 DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF SIFFORD, JEFFREY MARK 1671 Final Rejection Mar 05, 2021

Managing Takeda Vaccines Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month